Your browser doesn't support javascript.
loading
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.
Rodriguez-Ruiz, María E; Rodriguez, Inmaculada; Garasa, Saray; Barbes, Benigno; Solorzano, Jose Luis; Perez-Gracia, Jose Luis; Labiano, Sara; Sanmamed, Miguel F; Azpilikueta, Arantza; Bolaños, Elixabet; Sanchez-Paulete, Alfonso R; Aznar, M Angela; Rouzaut, Ana; Schalper, Kurt A; Jure-Kunkel, Maria; Melero, Ignacio.
Afiliação
  • Rodriguez-Ruiz ME; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain. University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona,
  • Rodriguez I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Garasa S; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Barbes B; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Solorzano JL; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Perez-Gracia JL; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Labiano S; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Sanmamed MF; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain. Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut.
  • Azpilikueta A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Bolaños E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Sanchez-Paulete AR; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Aznar MA; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Rouzaut A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.
  • Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
  • Jure-Kunkel M; Bristol-Myers Squibb, Lawrenceville, New Jersey. imelero@unav.es mrruiz@unav.es.
  • Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain. University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona,
Cancer Res ; 76(20): 5994-6005, 2016 10 15.
Article em En | MEDLINE | ID: mdl-27550452
Assuntos
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article